Lonsurf - RII Lonsurf (TAS-102) with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer. A randomized phase II study
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2536542
下载链接
链接失效反馈官方服务：
资源简介：
Primary objective:
• Progression-free survival (PFS)
Primary end-point:
• Progression-free survival (PFS)
创建时间：
2017-04-15
